c-myc protein kinetics during growth and differentiation of CD34 (MY10)-positive blast cells from normal human marrow.
We have used flow cytometry to quantitate nuclear c-myc protein, at each phase of the cell cycle, during in-vitro differentiation of CD34-positive stem cells isolated from normal human bone marrow by the monoclonal antibody, MY10. Mean c-myc protein levels in CD34-positive cells, consisting of greater than 70% blasts, are lower than a marrow fraction containing myeloid cells of intermediate maturation, but have an invariant proportional relationship, with regard to nuclear mass, over the cell cycle. The majority of these primitive cells are non-cycling, as revealed by DNA content. Under our assay conditions, nuclear c-myc protein distribution over the cell cycle did not change as these progenitors entered a proliferative phase in culture. In cultures containing factors supporting myeloid maturation, mean G0/G1 p62c-myc levels initially decline, then rise above starting values as promyelocytes and myelocytes differentiate from CD34-positive cells, and as proliferation begins. With further myeloid maturation, and while cell numbers are increasing, c-myc protein continues to increase. C-myc protein kinetics differ in cultures in which macrophages, rather than myeloid cells, predominate. These data indicate that a complex relationship exists between c-myc gene expression and proliferation, maturation and lineage in haemopoietic cells, and lend support to the notion that early down regulation may be causally associated with the differentiation process.
Bains
M A
MA
Department of Haematology, University of Wales College of Medicine, Cardiff.
Baines
P
P
Hodgetts
J
J
Hoy
T G
TG
Jacobs
A
A
D018952:Antigens, CD34; D000943:Antigens, Differentiation; D001853:Bone Marrow; D002453:Cell Cycle; D002454:Cell Differentiation; D002455:Cell Division; D002478:Cells, Cultured; D006412:Hematopoietic Stem Cells / Q000145:classification / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D007700:Kinetics; D010641:Phenotype; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000378:metabolism*; D016271:Proto-Oncogene Proteins c-myc
D018952:Antigens, CD34; D000943:Antigens, Differentiation; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc